GenomeFrontier Therapeutics TW Co., Ltd.
2 clinical trials · Sponsor
◉ Watch GenomeFrontier Therapeutics TW Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Long-term Study to Evaluate Safety and Persistence of GF-CART01 (NCT06985576) | GenomeFrontier Therapeutics TW Co., Ltd. | 2026-02-26 |
| A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies (NCT06703892) | GenomeFrontier Therapeutics TW Co., Ltd. | 2025-06-09 |
Track GenomeFrontier Therapeutics TW Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.